Live Breaking News & Updates on Aptamer Immune Stimulator Conjugate

Stay updated with breaking news from Aptamer immune stimulator conjugate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201: A Promising Approach to Address Under Medical Needs

/PRNewswire/ Aptamer Sciences Inc. (KOSDAQ, 291650) announced the filing of an Investigational New Drug (IND) application for the phase 1 clinical trial of. ....

Kyonggi Do , South Korea , Hong Jae Chon , Aprc Aptamer Radioligand , National Cancer Center , Aptamer Sciences Inc , Bundang Medical Center , Samsung Medical Center , Korean Ministry Of Food , Aptamer Sciences , Investigational New Drug , Korean Ministry , Drug Safety , Aptamer Drug Conjugate , East Asia , Nature Medicine , Medical Center , Severance Hospital , Aptamer Radioligand Conjugate , Aptamer Immune Stimulator Conjugate , Dong Il Han , Sciences Inc , Aptamer Sciences Inc ,